top of page
LISTEN TO THE POD
EMAIL SUBSCRIBE
WATCH ON THE PEN
🏠 HOME
📰 GLP-1 NEWS
📺 LIVE SHOW
🌕 ABOUT
OTP BOOK
💉 SHED
More
Use tab to navigate through the menu items.
Log In
DECODING GLP-1
An On The Pen Book
GET THE BOOK!
All Posts
Compound Tirzepatide
Zepbound
Mounjaro
Wegovy
Ozempic
Future Obesity Medicine
Compound Semaglutide
Zepbound Savings Card
Advocacy
Tirzepatide
Semaglutide
Novo Nordisk
FDA
Eli Lilly
FDA
pharmacies
compounded glp-1
503A Pharmacies
emvidutide
Pemvidutide
Trials
Semaglutide
Mazdutide
Type 2 Diabetes
Opinion
Retatrutide
Medicare
Rybelsus
Amycretin
Trulicity
Log in / Sign up
I Almost Collapsed at the Store. Was It Mounjaro?
Dave Knapp
Aug 28
2 min read
Compounded Tirzepatide: We Now Have the Judge’s Opinion, in Massive Blow to 503B’s
Dave Knapp
Jul 17
3 min read
Eli Lilly Earnings Call Recap
Dave Knapp
Jul 14
1 min read
Lilly’s Earnings Call Could Reveal Big Changes for Zepbound & Retatrutide: What They've Said and What We're Listening For
Dave Knapp
Feb 6
3 min read
Big Moves in the OFA v. FDA Case—But Does It Even Matter?
Dave Knapp
Jan 29
3 min read
Tirzepatide Cease-and-Desist Blitz: Eli Lilly Cracks Down Post-FDA Shortage Resolution
Dave Knapp
Jan 7
3 min read
Zepound and Mounjaro Shortage: JUDGE MAKES SHOCKING MOVE
Dave Knapp
Jan 6
2 min read
A Legal Twist in the Tirzepatide Shortage Saga
Dave Knapp
Jan 2
3 min read
Did the FDA Do Its Homework? The Critical Question in the Compounded Tirzepatide Case
Dave Knapp
Jan 1
4 min read
FDA Officially Removes Tirzepatide from Shortage: Is This The End of Zepbound and Mounjaro Copies?
Dave Knapp
Dec 19, 2024
2 min read
Compound Tirzepatide: All Eyes on December 19th
Dave Knapp
Dec 17, 2024
3 min read
Compound Tirzepatide Lives On! (For Now)
Dave Knapp
Nov 21, 2024
3 min read
What to Expect from Eli Lilly’s Q3 Earnings Call: With Live Updates
Dave Knapp
Oct 30, 2024
3 min read
OTP Exclusive: Lilly Has Been Quietly Exploring Alternative Avenues to Shut Down Tirzepatide Compounding
Dave Knapp
Oct 25, 2024
4 min read
Compound Tirzepatide Cease and Desist Avalanche Incoming Per Eli Lilly
Dave Knapp
Oct 10, 2024
4 min read
URGENT UPDATE: FDA Facing Major Blow in Compounded Tirzepatide Trial – Decision Coming SOON!
Dave Knapp
Oct 9, 2024
2 min read
The Human Toll of Removing Tirzepatide from the Shortage List: Voices from Those Who Rely on Compounded Medications
Dave Knapp
Oct 2, 2024
4 min read
Tirzepatide Breakthrough: 3-Year Study Reveals Stunning Weight Loss and Diabetes Defense
Dave Knapp
Aug 20, 2024
3 min read
The FDA, Eli Lilly, and the Legal Showdown Over Tirzepatide: Why the Courts Might Have the Final Say
Dave Knapp
Aug 14, 2024
3 min read
It Begins: Eli Lilly Fires off Round of Cease and Desist Letters to Tirzepatide Peddlers
Dave Knapp
Aug 11, 2024
5 min read
bottom of page